Global Diabetic Retinopathy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
The global Diabetic Retinopathy market size is projected to grow from US$ 7589.9 million in 2023 to US$ 11750 million in 2030; it is expected to grow at a CAGR of 6.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Diabetic Retinopathy Industry Forecast” looks at past sales and reviews total world Diabetic Retinopathy sales in 2023, providing a comprehensive analysis by region and market sector of projected Diabetic Retinopathy sales for 2024 through 2030. With Diabetic Retinopathy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Retinopathy industry.
This Insight Report provides a comprehensive analysis of the global Diabetic Retinopathy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetic Retinopathy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetic Retinopathy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Retinopathy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Retinopathy.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Retinopathy market by product type, application, key players and key regions and countries.
Segmentation by type
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
The global Diabetic Retinopathy market size is projected to grow from US$ 7589.9 million in 2023 to US$ 11750 million in 2030; it is expected to grow at a CAGR of 6.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Diabetic Retinopathy Industry Forecast” looks at past sales and reviews total world Diabetic Retinopathy sales in 2023, providing a comprehensive analysis by region and market sector of projected Diabetic Retinopathy sales for 2024 through 2030. With Diabetic Retinopathy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Retinopathy industry.
This Insight Report provides a comprehensive analysis of the global Diabetic Retinopathy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetic Retinopathy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetic Retinopathy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Retinopathy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Retinopathy.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Retinopathy market by product type, application, key players and key regions and countries.
Segmentation by type
- Laser Surgery
- Injection of Corticosteroids
- Anti-VEGF Drugs
- Vitrectomy
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Roche
- Novartis
- TEVA
- Alimera Sciences
- Regeneron Pharmaceuticals
- Boehringer Ingelheim
- Kowa Group
- Ohr Pharmaceutical
- Quark Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diabetic Retinopathy Market Size 2019-2030
2.1.2 Diabetic Retinopathy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Diabetic Retinopathy Segment by Type
2.2.1 Laser Surgery
2.2.2 Injection of Corticosteroids
2.2.3 Anti-VEGF Drugs
2.2.4 Vitrectomy
2.3 Diabetic Retinopathy Market Size by Type
2.3.1 Diabetic Retinopathy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
2.4 Diabetic Retinopathy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Diabetic Retinopathy Market Size by Application
2.5.1 Diabetic Retinopathy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
3 DIABETIC RETINOPATHY MARKET SIZE BY PLAYER
3.1 Diabetic Retinopathy Market Size Market Share by Players
3.1.1 Global Diabetic Retinopathy Revenue by Players (2019-2024)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Retinopathy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIABETIC RETINOPATHY BY REGIONS
4.1 Diabetic Retinopathy Market Size by Regions (2019-2024)
4.2 Americas Diabetic Retinopathy Market Size Growth (2019-2024)
4.3 APAC Diabetic Retinopathy Market Size Growth (2019-2024)
4.4 Europe Diabetic Retinopathy Market Size Growth (2019-2024)
4.5 Middle East & Africa Diabetic Retinopathy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Diabetic Retinopathy Market Size by Country (2019-2024)
5.2 Americas Diabetic Retinopathy Market Size by Type (2019-2024)
5.3 Americas Diabetic Retinopathy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Retinopathy Market Size by Region (2019-2024)
6.2 APAC Diabetic Retinopathy Market Size by Type (2019-2024)
6.3 APAC Diabetic Retinopathy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diabetic Retinopathy by Country (2019-2024)
7.2 Europe Diabetic Retinopathy Market Size by Type (2019-2024)
7.3 Europe Diabetic Retinopathy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diabetic Retinopathy by Region (2019-2024)
8.2 Middle East & Africa Diabetic Retinopathy Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Retinopathy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIABETIC RETINOPATHY MARKET FORECAST
10.1 Global Diabetic Retinopathy Forecast by Regions (2025-2030)
10.1.1 Global Diabetic Retinopathy Forecast by Regions (2025-2030)
10.1.2 Americas Diabetic Retinopathy Forecast
10.1.3 APAC Diabetic Retinopathy Forecast
10.1.4 Europe Diabetic Retinopathy Forecast
10.1.5 Middle East & Africa Diabetic Retinopathy Forecast
10.2 Americas Diabetic Retinopathy Forecast by Country (2025-2030)
10.2.1 United States Diabetic Retinopathy Market Forecast
10.2.2 Canada Diabetic Retinopathy Market Forecast
10.2.3 Mexico Diabetic Retinopathy Market Forecast
10.2.4 Brazil Diabetic Retinopathy Market Forecast
10.3 APAC Diabetic Retinopathy Forecast by Region (2025-2030)
10.3.1 China Diabetic Retinopathy Market Forecast
10.3.2 Japan Diabetic Retinopathy Market Forecast
10.3.3 Korea Diabetic Retinopathy Market Forecast
10.3.4 Southeast Asia Diabetic Retinopathy Market Forecast
10.3.5 India Diabetic Retinopathy Market Forecast
10.3.6 Australia Diabetic Retinopathy Market Forecast
10.4 Europe Diabetic Retinopathy Forecast by Country (2025-2030)
10.4.1 Germany Diabetic Retinopathy Market Forecast
10.4.2 France Diabetic Retinopathy Market Forecast
10.4.3 UK Diabetic Retinopathy Market Forecast
10.4.4 Italy Diabetic Retinopathy Market Forecast
10.4.5 Russia Diabetic Retinopathy Market Forecast
10.5 Middle East & Africa Diabetic Retinopathy Forecast by Region (2025-2030)
10.5.1 Egypt Diabetic Retinopathy Market Forecast
10.5.2 South Africa Diabetic Retinopathy Market Forecast
10.5.3 Israel Diabetic Retinopathy Market Forecast
10.5.4 Turkey Diabetic Retinopathy Market Forecast
10.5.5 GCC Countries Diabetic Retinopathy Market Forecast
10.6 Global Diabetic Retinopathy Forecast by Type (2025-2030)
10.7 Global Diabetic Retinopathy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Diabetic Retinopathy Product Offered
11.1.3 Bayer Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Diabetic Retinopathy Product Offered
11.2.3 Roche Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Diabetic Retinopathy Product Offered
11.3.3 Novartis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 TEVA
11.4.1 TEVA Company Information
11.4.2 TEVA Diabetic Retinopathy Product Offered
11.4.3 TEVA Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 TEVA Main Business Overview
11.4.5 TEVA Latest Developments
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Information
11.5.2 Alimera Sciences Diabetic Retinopathy Product Offered
11.5.3 Alimera Sciences Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alimera Sciences Main Business Overview
11.5.5 Alimera Sciences Latest Developments
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Information
11.6.2 Regeneron Pharmaceuticals Diabetic Retinopathy Product Offered
11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Regeneron Pharmaceuticals Main Business Overview
11.6.5 Regeneron Pharmaceuticals Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Diabetic Retinopathy Product Offered
11.7.3 Boehringer Ingelheim Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Kowa Group
11.8.1 Kowa Group Company Information
11.8.2 Kowa Group Diabetic Retinopathy Product Offered
11.8.3 Kowa Group Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kowa Group Main Business Overview
11.8.5 Kowa Group Latest Developments
11.9 Ohr Pharmaceutical
11.9.1 Ohr Pharmaceutical Company Information
11.9.2 Ohr Pharmaceutical Diabetic Retinopathy Product Offered
11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ohr Pharmaceutical Main Business Overview
11.9.5 Ohr Pharmaceutical Latest Developments
11.10 Quark Pharmaceuticals
11.10.1 Quark Pharmaceuticals Company Information
11.10.2 Quark Pharmaceuticals Diabetic Retinopathy Product Offered
11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quark Pharmaceuticals Main Business Overview
11.10.5 Quark Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diabetic Retinopathy Market Size 2019-2030
2.1.2 Diabetic Retinopathy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Diabetic Retinopathy Segment by Type
2.2.1 Laser Surgery
2.2.2 Injection of Corticosteroids
2.2.3 Anti-VEGF Drugs
2.2.4 Vitrectomy
2.3 Diabetic Retinopathy Market Size by Type
2.3.1 Diabetic Retinopathy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
2.4 Diabetic Retinopathy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Diabetic Retinopathy Market Size by Application
2.5.1 Diabetic Retinopathy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
3 DIABETIC RETINOPATHY MARKET SIZE BY PLAYER
3.1 Diabetic Retinopathy Market Size Market Share by Players
3.1.1 Global Diabetic Retinopathy Revenue by Players (2019-2024)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Retinopathy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIABETIC RETINOPATHY BY REGIONS
4.1 Diabetic Retinopathy Market Size by Regions (2019-2024)
4.2 Americas Diabetic Retinopathy Market Size Growth (2019-2024)
4.3 APAC Diabetic Retinopathy Market Size Growth (2019-2024)
4.4 Europe Diabetic Retinopathy Market Size Growth (2019-2024)
4.5 Middle East & Africa Diabetic Retinopathy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Diabetic Retinopathy Market Size by Country (2019-2024)
5.2 Americas Diabetic Retinopathy Market Size by Type (2019-2024)
5.3 Americas Diabetic Retinopathy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Retinopathy Market Size by Region (2019-2024)
6.2 APAC Diabetic Retinopathy Market Size by Type (2019-2024)
6.3 APAC Diabetic Retinopathy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diabetic Retinopathy by Country (2019-2024)
7.2 Europe Diabetic Retinopathy Market Size by Type (2019-2024)
7.3 Europe Diabetic Retinopathy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diabetic Retinopathy by Region (2019-2024)
8.2 Middle East & Africa Diabetic Retinopathy Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Retinopathy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIABETIC RETINOPATHY MARKET FORECAST
10.1 Global Diabetic Retinopathy Forecast by Regions (2025-2030)
10.1.1 Global Diabetic Retinopathy Forecast by Regions (2025-2030)
10.1.2 Americas Diabetic Retinopathy Forecast
10.1.3 APAC Diabetic Retinopathy Forecast
10.1.4 Europe Diabetic Retinopathy Forecast
10.1.5 Middle East & Africa Diabetic Retinopathy Forecast
10.2 Americas Diabetic Retinopathy Forecast by Country (2025-2030)
10.2.1 United States Diabetic Retinopathy Market Forecast
10.2.2 Canada Diabetic Retinopathy Market Forecast
10.2.3 Mexico Diabetic Retinopathy Market Forecast
10.2.4 Brazil Diabetic Retinopathy Market Forecast
10.3 APAC Diabetic Retinopathy Forecast by Region (2025-2030)
10.3.1 China Diabetic Retinopathy Market Forecast
10.3.2 Japan Diabetic Retinopathy Market Forecast
10.3.3 Korea Diabetic Retinopathy Market Forecast
10.3.4 Southeast Asia Diabetic Retinopathy Market Forecast
10.3.5 India Diabetic Retinopathy Market Forecast
10.3.6 Australia Diabetic Retinopathy Market Forecast
10.4 Europe Diabetic Retinopathy Forecast by Country (2025-2030)
10.4.1 Germany Diabetic Retinopathy Market Forecast
10.4.2 France Diabetic Retinopathy Market Forecast
10.4.3 UK Diabetic Retinopathy Market Forecast
10.4.4 Italy Diabetic Retinopathy Market Forecast
10.4.5 Russia Diabetic Retinopathy Market Forecast
10.5 Middle East & Africa Diabetic Retinopathy Forecast by Region (2025-2030)
10.5.1 Egypt Diabetic Retinopathy Market Forecast
10.5.2 South Africa Diabetic Retinopathy Market Forecast
10.5.3 Israel Diabetic Retinopathy Market Forecast
10.5.4 Turkey Diabetic Retinopathy Market Forecast
10.5.5 GCC Countries Diabetic Retinopathy Market Forecast
10.6 Global Diabetic Retinopathy Forecast by Type (2025-2030)
10.7 Global Diabetic Retinopathy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Diabetic Retinopathy Product Offered
11.1.3 Bayer Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Diabetic Retinopathy Product Offered
11.2.3 Roche Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Diabetic Retinopathy Product Offered
11.3.3 Novartis Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 TEVA
11.4.1 TEVA Company Information
11.4.2 TEVA Diabetic Retinopathy Product Offered
11.4.3 TEVA Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 TEVA Main Business Overview
11.4.5 TEVA Latest Developments
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Information
11.5.2 Alimera Sciences Diabetic Retinopathy Product Offered
11.5.3 Alimera Sciences Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alimera Sciences Main Business Overview
11.5.5 Alimera Sciences Latest Developments
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Information
11.6.2 Regeneron Pharmaceuticals Diabetic Retinopathy Product Offered
11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Regeneron Pharmaceuticals Main Business Overview
11.6.5 Regeneron Pharmaceuticals Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Diabetic Retinopathy Product Offered
11.7.3 Boehringer Ingelheim Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Kowa Group
11.8.1 Kowa Group Company Information
11.8.2 Kowa Group Diabetic Retinopathy Product Offered
11.8.3 Kowa Group Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kowa Group Main Business Overview
11.8.5 Kowa Group Latest Developments
11.9 Ohr Pharmaceutical
11.9.1 Ohr Pharmaceutical Company Information
11.9.2 Ohr Pharmaceutical Diabetic Retinopathy Product Offered
11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ohr Pharmaceutical Main Business Overview
11.9.5 Ohr Pharmaceutical Latest Developments
11.10 Quark Pharmaceuticals
11.10.1 Quark Pharmaceuticals Company Information
11.10.2 Quark Pharmaceuticals Diabetic Retinopathy Product Offered
11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quark Pharmaceuticals Main Business Overview
11.10.5 Quark Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Diabetic Retinopathy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Laser Surgery
Table 3. Major Players of Injection of Corticosteroids
Table 4. Major Players of Anti-VEGF Drugs
Table 5. Major Players of Vitrectomy
Table 6. Diabetic Retinopathy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 9. Diabetic Retinopathy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 12. Global Diabetic Retinopathy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Diabetic Retinopathy Revenue Market Share by Player (2019-2024)
Table 14. Diabetic Retinopathy Key Players Head office and Products Offered
Table 15. Diabetic Retinopathy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Diabetic Retinopathy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Diabetic Retinopathy Market Size Market Share by Regions (2019-2024)
Table 20. Global Diabetic Retinopathy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Diabetic Retinopathy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Diabetic Retinopathy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Diabetic Retinopathy Market Size Market Share by Country (2019-2024)
Table 24. Americas Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 26. Americas Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 28. APAC Diabetic Retinopathy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Table 30. APAC Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 32. APAC Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 34. Europe Diabetic Retinopathy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Diabetic Retinopathy Market Size Market Share by Country (2019-2024)
Table 36. Europe Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 38. Europe Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Diabetic Retinopathy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Diabetic Retinopathy
Table 47. Key Market Challenges & Risks of Diabetic Retinopathy
Table 48. Key Industry Trends of Diabetic Retinopathy
Table 49. Global Diabetic Retinopathy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Diabetic Retinopathy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Diabetic Retinopathy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Diabetic Retinopathy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Bayer Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 54. Bayer Diabetic Retinopathy Product Offered
Table 55. Bayer Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Roche Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 59. Roche Diabetic Retinopathy Product Offered
Table 60. Roche Main Business
Table 61. Roche Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Novartis Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 64. Novartis Diabetic Retinopathy Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Latest Developments
Table 68. TEVA Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 69. TEVA Diabetic Retinopathy Product Offered
Table 70. TEVA Main Business
Table 71. TEVA Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. TEVA Latest Developments
Table 73. Alimera Sciences Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 74. Alimera Sciences Diabetic Retinopathy Product Offered
Table 75. Alimera Sciences Main Business
Table 76. Alimera Sciences Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Alimera Sciences Latest Developments
Table 78. Regeneron Pharmaceuticals Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 79. Regeneron Pharmaceuticals Diabetic Retinopathy Product Offered
Table 80. Regeneron Pharmaceuticals Main Business
Table 81. Regeneron Pharmaceuticals Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Regeneron Pharmaceuticals Latest Developments
Table 83. Boehringer Ingelheim Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 84. Boehringer Ingelheim Diabetic Retinopathy Product Offered
Table 85. Boehringer Ingelheim Main Business
Table 86. Boehringer Ingelheim Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Kowa Group Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 89. Kowa Group Diabetic Retinopathy Product Offered
Table 90. Kowa Group Main Business
Table 91. Kowa Group Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Kowa Group Latest Developments
Table 93. Ohr Pharmaceutical Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 94. Ohr Pharmaceutical Diabetic Retinopathy Product Offered
Table 95. Ohr Pharmaceutical Main Business
Table 96. Ohr Pharmaceutical Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Ohr Pharmaceutical Latest Developments
Table 98. Quark Pharmaceuticals Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 99. Quark Pharmaceuticals Diabetic Retinopathy Product Offered
Table 100. Quark Pharmaceuticals Main Business
Table 101. Quark Pharmaceuticals Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Quark Pharmaceuticals Latest Developments
Table 1. Diabetic Retinopathy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Laser Surgery
Table 3. Major Players of Injection of Corticosteroids
Table 4. Major Players of Anti-VEGF Drugs
Table 5. Major Players of Vitrectomy
Table 6. Diabetic Retinopathy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 9. Diabetic Retinopathy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 12. Global Diabetic Retinopathy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Diabetic Retinopathy Revenue Market Share by Player (2019-2024)
Table 14. Diabetic Retinopathy Key Players Head office and Products Offered
Table 15. Diabetic Retinopathy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Diabetic Retinopathy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Diabetic Retinopathy Market Size Market Share by Regions (2019-2024)
Table 20. Global Diabetic Retinopathy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Diabetic Retinopathy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Diabetic Retinopathy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Diabetic Retinopathy Market Size Market Share by Country (2019-2024)
Table 24. Americas Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 26. Americas Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 28. APAC Diabetic Retinopathy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Table 30. APAC Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 32. APAC Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 34. Europe Diabetic Retinopathy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Diabetic Retinopathy Market Size Market Share by Country (2019-2024)
Table 36. Europe Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 38. Europe Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Diabetic Retinopathy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Diabetic Retinopathy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Diabetic Retinopathy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Diabetic Retinopathy
Table 47. Key Market Challenges & Risks of Diabetic Retinopathy
Table 48. Key Industry Trends of Diabetic Retinopathy
Table 49. Global Diabetic Retinopathy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Diabetic Retinopathy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Diabetic Retinopathy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Diabetic Retinopathy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Bayer Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 54. Bayer Diabetic Retinopathy Product Offered
Table 55. Bayer Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Roche Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 59. Roche Diabetic Retinopathy Product Offered
Table 60. Roche Main Business
Table 61. Roche Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Novartis Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 64. Novartis Diabetic Retinopathy Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Latest Developments
Table 68. TEVA Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 69. TEVA Diabetic Retinopathy Product Offered
Table 70. TEVA Main Business
Table 71. TEVA Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. TEVA Latest Developments
Table 73. Alimera Sciences Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 74. Alimera Sciences Diabetic Retinopathy Product Offered
Table 75. Alimera Sciences Main Business
Table 76. Alimera Sciences Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Alimera Sciences Latest Developments
Table 78. Regeneron Pharmaceuticals Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 79. Regeneron Pharmaceuticals Diabetic Retinopathy Product Offered
Table 80. Regeneron Pharmaceuticals Main Business
Table 81. Regeneron Pharmaceuticals Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Regeneron Pharmaceuticals Latest Developments
Table 83. Boehringer Ingelheim Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 84. Boehringer Ingelheim Diabetic Retinopathy Product Offered
Table 85. Boehringer Ingelheim Main Business
Table 86. Boehringer Ingelheim Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Kowa Group Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 89. Kowa Group Diabetic Retinopathy Product Offered
Table 90. Kowa Group Main Business
Table 91. Kowa Group Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Kowa Group Latest Developments
Table 93. Ohr Pharmaceutical Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 94. Ohr Pharmaceutical Diabetic Retinopathy Product Offered
Table 95. Ohr Pharmaceutical Main Business
Table 96. Ohr Pharmaceutical Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Ohr Pharmaceutical Latest Developments
Table 98. Quark Pharmaceuticals Details, Company Type, Diabetic Retinopathy Area Served and Its Competitors
Table 99. Quark Pharmaceuticals Diabetic Retinopathy Product Offered
Table 100. Quark Pharmaceuticals Main Business
Table 101. Quark Pharmaceuticals Diabetic Retinopathy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Quark Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Diabetic Retinopathy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diabetic Retinopathy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Diabetic Retinopathy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Diabetic Retinopathy Sales Market Share by Country/Region (2023)
Figure 8. Diabetic Retinopathy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Diabetic Retinopathy Market Size Market Share by Type in 2023
Figure 10. Diabetic Retinopathy in Hospitals
Figure 11. Global Diabetic Retinopathy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Diabetic Retinopathy in Clinics
Figure 13. Global Diabetic Retinopathy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Diabetic Retinopathy in Others
Figure 15. Global Diabetic Retinopathy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Diabetic Retinopathy Market Size Market Share by Application in 2023
Figure 17. Global Diabetic Retinopathy Revenue Market Share by Player in 2023
Figure 18. Global Diabetic Retinopathy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Diabetic Retinopathy Value Market Share by Country in 2023
Figure 24. United States Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Diabetic Retinopathy Market Size Market Share by Region in 2023
Figure 29. APAC Diabetic Retinopathy Market Size Market Share by Type in 2023
Figure 30. APAC Diabetic Retinopathy Market Size Market Share by Application in 2023
Figure 31. China Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Diabetic Retinopathy Market Size Market Share by Country in 2023
Figure 38. Europe Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 57. United States Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 61. China Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 65. India Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 68. France Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 69. UK Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 78. Global Diabetic Retinopathy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Diabetic Retinopathy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Diabetic Retinopathy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diabetic Retinopathy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Diabetic Retinopathy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Diabetic Retinopathy Sales Market Share by Country/Region (2023)
Figure 8. Diabetic Retinopathy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Diabetic Retinopathy Market Size Market Share by Type in 2023
Figure 10. Diabetic Retinopathy in Hospitals
Figure 11. Global Diabetic Retinopathy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Diabetic Retinopathy in Clinics
Figure 13. Global Diabetic Retinopathy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Diabetic Retinopathy in Others
Figure 15. Global Diabetic Retinopathy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Diabetic Retinopathy Market Size Market Share by Application in 2023
Figure 17. Global Diabetic Retinopathy Revenue Market Share by Player in 2023
Figure 18. Global Diabetic Retinopathy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Diabetic Retinopathy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Diabetic Retinopathy Value Market Share by Country in 2023
Figure 24. United States Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Diabetic Retinopathy Market Size Market Share by Region in 2023
Figure 29. APAC Diabetic Retinopathy Market Size Market Share by Type in 2023
Figure 30. APAC Diabetic Retinopathy Market Size Market Share by Application in 2023
Figure 31. China Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Diabetic Retinopathy Market Size Market Share by Country in 2023
Figure 38. Europe Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Diabetic Retinopathy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Diabetic Retinopathy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 57. United States Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 61. China Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 65. India Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 68. France Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 69. UK Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Diabetic Retinopathy Market Size 2025-2030 ($ Millions)
Figure 78. Global Diabetic Retinopathy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Diabetic Retinopathy Market Size Market Share Forecast by Application (2025-2030)
